XML 22 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2021
Sep. 30, 2020
 [1]
Net Income $ 47,723 $ 195,539
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion, and amortization 201,663 103,372
Deferred income taxes 3,129 (524)
Share-based compensation 37,910 13,901
(Gain) loss on the disposal of property, plant, and equipment, and intangibles, net 537 178
Loss on sale of businesses, net 404 5
Fair value adjustment related to convertible debt liability 27,806 0
Amortization of inventory fair value adjustments 85,154 0
Other items 7,986 5,460
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable, net 15,932 88,134
Inventories, net (57,897) (27,080)
Other current assets (66,337) (355)
Accounts payable (260) (27,545)
Accruals and other, net (34,984) (55,012)
Net cash provided by operating activities 268,766 296,073
Investing activities:    
Purchases of property, plant, equipment, and intangibles, net (133,369) (110,746)
Proceeds from the sale of property, plant, equipment, and intangibles 387 275
Acquisition of businesses, net of cash acquired (547,353) 0
Payments for (Proceeds from) Other Investing Activities 0 (2,392)
Net cash used in investing activities (680,335) (112,863)
Financing activities:    
Proceeds from Issuance of Senior Long-term Debt 1,350,000 0
Proceeds from Issuance of Secured Debt 650,000 0
Payments on long-term obligations (721,284) (35,000)
Repayments of Convertible Debt (371,361) 0
Repayments of Secured Debt (125,000) 0
Proceeds (Payments) under credit facilities, net (65,021) (107,162)
Deferred financing fees and debt issuance costs (17,343) 0
Acquisition related deferred or contingent consideration (25,262) (42)
Repurchases of ordinary shares (24,751) (14,434)
Cash dividends paid to ordinary shareholders (77,107) (65,560)
Payments to Noncontrolling Interests (997) 0
Proceeds from issuance of equity to minority shareholders 0 2,258
Proceeds from (Payments for) Other Financing Activities 7,829 20,621
Net cash used in financing activities 579,703 (199,319)
Effect of exchange rate changes on cash and cash equivalents (5,171) 8,556
Increase (decrease) in cash and cash equivalents 162,963 (7,553)
Cash and cash equivalents at beginning of period 220,531 319,581
Cash and cash equivalents at end of period $ 383,494 $ 312,028
[1] Certain amounts have been adjusted to reflect the change in inventory accounting method, as described in our Annual Report on Form 10-K filed with the SEC on May 28, 2021.